Access cutting-edge myelodysplastic syndrome treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access myelodysplastic syndrome specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myelodysplastic syndrome treatment provided free
The purpose of the study is to compare the efficacy and safety of Luspatercept vs epoetin alfa in the treatment of anemia in adults due to IPSS-R very low, low, intermediate-risk MDS in ESA-naïve participants who are non-transfusion dependent (NTD).
Sponsor: Bristol-Myers Squibb
Check if you qualify for this myelodysplastic syndrome clinical trial in Los Angeles, CA
If you're searching for myelodysplastic syndrome treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myelodysplastic syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.